FDA Approves FYREMADEL — Ferring Pharmaceuticals Inc.
Ferring Pharmaceuticals Inc. announced the FDA approval of its ANDA for Ganirelix Acetate, positioning the company to capitalize on the expiration of FYREMADEL exclusivity and secure market share in the reproductive health sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day